Citation 114482

BAGARSRA,O: WHITTLE,P: HEINS,B: POMERANTZ,RJ:. (1991). ANTI-HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ACTIVITY OF SULFATED MONOSACCHARIDES: COMPARISON WITH SULFATED POLYSACCHARIDES AND OTHER POLYIONS.. 164(6)

Citation Details

Title	ANTI-HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ACTIVITY OF SULFATED MONOSACCHARIDES: COMPARISON WITH SULFATED POLYSACCHARIDES AND OTHER POLYIONS.
Authors	BAGARSRA,O: WHITTLE,P: HEINS,B: POMERANTZ,RJ:
Year	1991
Volume	164
Issue	6

Summary

Year: 1991

Journal: Unknown

Organisms and Their Experiments (13)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPARIN SULFATE	ACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HEPARIN SULFATE	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPARIN SULFATE	ACTIVE
4	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPARIN SULFATE	ACTIVE
5	PROTHROMBIN TIME DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPARIN SULFATE	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPARIN MONOSULFATE	ACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HEPARIN MONOSULFATE	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPARIN MONOSULFATE	INACTIVE
4	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPARIN MONOSULFATE	ACTIVE
5	PROTHROMBIN TIME DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPARIN MONOSULFATE	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYALURONIC ACID	INACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HYALURONIC ACID	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYALURONIC ACID	WEAK ACTIVITY
4	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HYALURONIC ACID	WEAK ACTIVITY
5	PROTHROMBIN TIME DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	HYALURONIC ACID	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHONDROITIN SULATE(SHARK)	ACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CHONDROITIN SULATE(SHARK)	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHONDROITIN SULATE(SHARK)	ACTIVE
4	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHONDROITIN SULATE(SHARK)	WEAK ACTIVITY
5	PROTHROMBIN TIME DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	CHONDROITIN SULATE(SHARK)	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHONDROITIN SULFATE(BOVINE)	ACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CHONDROITIN SULFATE(BOVINE)	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHONDROITIN SULFATE(BOVINE)	ACTIVE
4	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHONDROITIN SULFATE(BOVINE)	WEAK ACTIVITY
5	PROTHROMBIN TIME INCREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	CHONDROITIN SULFATE(BOVINE)	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CARRAGEENAN	ACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARRAGEENAN	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CARRAGEENAN	ACTIVE
4	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CARRAGEENAN	ACTIVE
5	PROTHROMBIN TIME DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	CARRAGEENAN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PENTOSAN POLYSULFATE*	ACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PENTOSAN POLYSULFATE*	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PENTOSAN POLYSULFATE*	ACTIVE
4	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PENTOSAN POLYSULFATE*	ACTIVE
5	PROTHROMBIN TIME DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	PENTOSAN POLYSULFATE*	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUCOIDIN	ACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FUCOIDIN	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUCOIDIN	ACTIVE
4	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FUCOIDIN	INACTIVE
5	PROTHROMBIN TIME DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	FUCOIDIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEXTRAN SULFATE(500,000 DA)*	ACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DEXTRAN SULFATE(500,000 DA)*	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEXTRAN SULFATE(500,000 DA)*	ACTIVE
4	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DEXTRAN SULFATE(500,000 DA)*	ACTIVE
5	PROTHROMBIN TIME INCREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	DEXTRAN SULFATE(500,000 DA)*	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEXTRAN SULFATE(50,000 DA)*	ACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DEXTRAN SULFATE(50,000 DA)*	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEXTRAN SULFATE(50,000 DA)*	ACTIVE
4	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DEXTRAN SULFATE(50,000 DA)*	ACTIVE
5	PROTHROMBIN TIME INCREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	DEXTRAN SULFATE(50,000 DA)*	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEXTRAN SULFATE(5,000 DA)*	ACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DEXTRAN SULFATE(5,000 DA)*	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEXTRAN SULFATE(5,000 DA)*	ACTIVE
4	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DEXTRAN SULFATE(5,000 DA)*	ACTIVE
5	PROTHROMBIN TIME INCREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	DEXTRAN SULFATE(5,000 DA)*	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEXTRAN(150000 DA)	INACTIVE
2	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DEXTRAN(150000 DA)	INACTIVE
3	PROTHROMBIN TIME DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	DEXTRAN(150000 DA)	ACTIVE
4	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEXTRAN(78500 DA)	INACTIVE
5	PROTHROMBIN TIME DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	DEXTRAN(78500 DA)	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	INOSITOL HEXASULFATE	ACTIVE
2	ANTICOAGULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	INOSITOL HEXASULFATE	INACTIVE
3	PROTHROMBIN TIME INCREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	INOSITOL HEXASULFATE	WEAK ACTIVITY

Show SPARQL Queries (1)